Goodwin Procter LLP, a leading Am Law 50 and Global 50 law firm, has been named the 2015 U.S. News-Best Lawyers’ “Law Firm of the Year” for Biotechnology Law. This is the third consecutive year the firm has received this honor.
Each year, U.S. News-Best Lawyers recognizes one law firm per legal practice area based on the firm’s performance in client surveys, as well as from feedback from peer attorneys at other firms and information provided to the publication as part of its annual law firm ranking survey.
With more than 100 experienced life sciences attorneys, Goodwin has one of the leading biotechnology practices in the United States. The firm’s fully integrated practice, including corporate, intellectual property, partnering, regulatory and litigation attorneys, allows it to effectively serve clients at every stage of the company life cycle. Its clients include more than 400 private and public life sciences companies, from start-ups to Fortune 100 corporations.
“We are thrilled to once again be recognized by U.S. News-Best Lawyers as the biotech law firm of the year,” said Mitchell Bloom, Goodwin partner and national co-chair of the firm’s Life Sciences Practice. “Our attorneys work exceptionally hard to provide sophisticated, thoughtful and practical advice to our clients at every stage of their business and to be true business partners. We could not be more proud to have this work recognized by our clients and peers.”
Kingsley Taft, national co-chair of the firm’s Life Science Practice, added “We are proud to represent some of the most innovative and fastest growing companies in the life sciences space. From company formation to patent protection, licensing, FDA advice, M&A and IPOs, we provide across-the-board expertise to help our clients tackle real issues and advance their business objectives. It is an honor to have our full service approach recognized as the best-of-the-best for the third year in a row.”
Goodwin’s Life Sciences Practice is consistently ranked among the best in the industry. In addition to Biotech Law Firm of the Year for three years running, in the last two years the group was recognized as the most active law firm in biotech/pharma licensing transactions and most active in biotech/venture capital investments. Recently, Goodwin advised SAGE Therapeutics, Zafgen and ProQR Therapeutics on their respective initial public offerings, representing three of the top 10 most successful biotech IPOs this year. Goodwin also advised Nogra Pharma on its global license agreement with Celgene, a deal with the largest upfront payment for an in-licensing deal in the last 10 years.
The 2015 U.S. News – Best Lawyers “Best Law Firms” survey also ranked Goodwin’s Biotechnology practice in Tier 1 at the national level for the fourth consecutive year. In total, the firm was ranked in 109 national and metropolitan practice areas in 2015. For the complete list of Goodwin’s recognition in the survey, please click here.
Firms included in the 2015 “Best Law Firms” list are recognized for professional excellence with persistently impressive ratings from clients and peers. Achieving a tiered ranking signals a unique combination of quality law practice and breadth of legal expertise. The 2015 rankings are based on the highest number of participating firms and highest number of client ballots on record. To be eligible for a ranking, a firm must have a lawyer listed in The Best Lawyers in America, which recognizes the top 4 percent of practicing attorneys in the US. Over 17,000 attorneys provided over 600,000 law firm assessments, and almost 7,500 clients provided close to 40,000 evaluations.
About Goodwin Procter
Goodwin Procter LLP is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 850 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinprocter.com. Follow us on Twitter @goodwinprocter.